HAEM5:Adult T-cell leukaemia/lymphoma: Difference between revisions
| [checked revision] | [checked revision] |
| Line 105: | Line 105: | ||
!Established Clinical Significance Per Guidelines - Yes or No (Source) | !Established Clinical Significance Per Guidelines - Yes or No (Source) | ||
!Clinical Relevance Details/Other Notes | !Clinical Relevance Details/Other Notes | ||
|- | |||
|1 | |||
|Amp | |||
|1p36 | |||
|''H6PD, VPS13D, PRDM2'' | |||
| | |||
|No | |||
| | |||
|- | |||
|1 | |||
|Gain | |||
|1q | |||
|Multiple candidates | |||
| | |||
|No | |||
|1q gains common in lymphoma-type ATLL | |||
|- | |- | ||
| | | | ||